| Autor: |
Krylova, S. G., Kiseleva, E. A., Povet'eva, T. N., Nesterova, Yu. V., Rybalkina, O. Yu., Kul'pin, P. V., Afanas'eva, O. G., Kulagina, D. A., Eremina, V. V., Baibakova, O. V., Zueva, E. P., Suslov, N. I., Sysolyatin, S. V., Zhdanov, V. V. |
| Zdroj: |
Bulletin of Experimental Biology & Medicine; Dec2022, Vol. 174 Issue 2, p230-235, 6p |
| Abstrakt: |
Analysis of specific pharmacological activity evaluated high antinociceptive efficacy of the first synthesized compound 10-di(ethoxyacetyl)-2,6,8,12-tetraacetyl-2,4,6,8,10,12-hexaazatetracyclo[5,5,0,03,11,05,9]dodecane (ethowurtzine) in models of somatogenic pain of different genesis (thermal, visceral pain, mechanical compression of paw).The new molecule from the class of hexaazaisowurtzitane effectively blocks nociceptive reactions at the supraspinal and peripheral levels of pain sensitivity organization. The effect of ethowurtzine was comparable or exceeded the effect of tramadol. The obtained results prove the possibility of creating new pharmacologically active molecules based on the high-energy substance hexaazaisowurtzitane. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink